InvestSMART

PainChek Ltd (ASX: PCK) - Share Price

Current share price for PCK : $0.105 0.005 (5%)+

PainChek Ltd (PCK), an ASX-listed company, is the world's first regulatory-cleared medical device for the assessment of pain, enabling best-practice pain management for people living with pain in any environment, from those who cannot reliably self-report their pain, those who can, and for those whose ability to self-report their pain fluctuates.

PCK General Information +

ASX Code PCK
Website N/A
Industry/Sector Health Care Technology
Market Cap ($M) 21
PCK Share Price $0.105
Day High $0.105
Day Low $0.105
Last Close $0.100
PCK Share Price Movement $0.00 ( 5% )
Prices as at 16:40, 22 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

PainChek Ltd (PCK) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from PainChek Ltd (PCK) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

PainChek Ltd (PCK) price-sensitive announcements

PCK - PainChek receives $1.123 million R&D tax incentive refund
PainChek Ltd announced the receipt of a $1.123 million R&D tax incentive refund for the 20
PainChek Ltd (PCK)
22 Jul 2026 | 8:29 AM
PCK - US MedTech leader Karen Holzberger appointed CEO
PainChek Ltd (ASX: PCK), an Australian company known for its AI-powered pain assessment an
PainChek Ltd (PCK)
20 Jul 2026 | 8:58 AM
PCK - CEO Transition
PainChek Ltd announced the immediate transition of its CEO and Managing Director, Philip D
PainChek Ltd (PCK)
6 Jul 2026 | 4:33 PM
PCK - PainChek secures A$5.5m note to fund US expansion
PainChek Ltd has announced a A$5.5 million convertible note financing to support its expan
PainChek Ltd (PCK)
22 May 2026 | 9:05 AM

PainChek Ltd (PCK) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
PainChek Ltd (PCK)
ORDINARY FULLY PAID
Health Care $22 PainChek receives $1.123 million R&D tax incentive refund 22 Jul 2026 8:29AM $0.100 $0.105 risen by 5%
PainChek Ltd (PCK)
ORDINARY FULLY PAID
Health Care $22 US MedTech leader Karen Holzberger appointed CEO 20 Jul 2026 8:58AM $0.105 $0.105 fallen by 0%
PainChek Ltd (PCK)
ORDINARY FULLY PAID
Health Care $22 Final Director's Interest Notice 8 Jul 2026 1:44PM $0.115 $0.105 fallen by 8.70%
PainChek Ltd (PCK)
ORDINARY FULLY PAID
Health Care $22 CEO Transition 6 Jul 2026 4:33PM $0.100 $0.105 risen by 5%
PainChek Ltd (PCK)
ORDINARY FULLY PAID
Health Care $22 Notification of cessation of securities - PCK 3 Jul 2026 3:24PM $0.105 $0.105 fallen by 0%
PainChek Ltd (PCK)
ORDINARY FULLY PAID
Health Care $22 Change of Director's Interest Notice x5 26 Jun 2026 5:12PM $0.100 $0.105 risen by 5%

PCK Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$7.67 -$4.40 -20.90% 0.00 0.00 0.00% 0.0%
2024A -$8.31 -$5.60 -3.00% 0.00 0.00 0.00% 0.0%
2023A -$7.57 -$5.80 15.70% 0.00 0.00 0.00% 0.0%

PCK Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
4DMedical Limited (4DX) $2,051M 0.3304 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
PainChek Ltd (PCK) $21M -0.2093 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $18,809M 0.3919 0.2545 0.2962 163.5241 130.3504 100.5642 0.31% 0.39% 0.51%

PCK Directors

Name Position Start Date
Ms Lilian (Lil) Bianchi Non-Executive Chairman, Non-Executive Director 25 May 2026
Mr Adam Stuart Davey Non-Executive Director 29 Sep 2014
Mr John Murray Non-Executive Director 30 Sep 2016
Mr Ross Harricks Non-Executive Director 30 Sep 2016
Ms Cynthia Payne Non-Executive Director 30 Mar 2022

PainChek Ltd (PCK) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
22 Dec 2025 DAFFAS, Philip Issued Direct Shares 147,059 $0.340 $50,000.000
22 Dec 2025 PAYNE, Cynthia Issued Direct Shares 29,412 $0.340 $10,000.000
19 Dec 2024 DAVEY, Adam Issued Indirect Shares 767,280 $0.025 $19,182.000

See all changes in directors' interest & trades for PainChek Ltd (PCK) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

PCK Management

Name Position
Natalie Sylvia Climo Company Secretary
Andy Hoggan Interim Chief Executive Officer

PCK Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in PainChek Ltd (PCK). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
133,481,250 (6.47%) Peters Investments Pty Ltd

PCK Calendar of Events

Date Event
26 February 2027 Report (Interim)
29 September 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.